QQQ $ 601.65 $ -3.54 (-0.58 %)
DIA $ 460.94 $ -2.42 (-0.52 %)
SPY $ 662.73 $ -4.16 (-0.62 %)
TLT $ 91.21 $ 0.71 (0.78 %)
GLD $ 394.19 $ 3.05 (0.78 %)
$ 0.69887
-- x --
-- x --
-- - --
$ 0.25 - $ 1.13
361,752
na
na
$ 1.18
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 enzo-biochem-q4-eps-001-sales-753m-cash-524m

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.01) per share. The company reported $7.53 million in sales this quarter.

 enzo-biochem-ordered-to-pay-45m-for-failing-to-protect-patient-data

- Reuters Citing NY Attorney General

 why-pricesmart-shares-are-trading-higher-by-around-5-here-are-20-stocks-moving-premarket

Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expecte...

 heico-emcor-group-and-3-stocks-to-watch-heading-into-monday

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as fol...

 enzo-biochem-q1-eps-013-up-from-022-yoy

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.13) per share. This is a 40.91 percent increase over losses of $(0.22)...

 enzo-biochem-announces-departure-of-hamid-erfanian-and-appointment-of-kara-cannon-as-interim-ceo-effective-september-5-2023

 Enzo Biochem, Inc. (NYSE:ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION